Wound Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Wound Care Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Wound Care Market

The wound care market size was valued at USD 19.63 billion in 2023, and the market is now projected to grow from USD 20.86 billion in 2024 to USD 37.08 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2024-2032.

The pandemic had an adverse effect on the wound care market growth. In 2020, few marketplace players suggested sales declines as a result of the pandemic. During the primary part of the year, essential nations redirected healthcare resources, inclusive of beds, nurses, and workers, to treat COVID-19 sufferers. Wound treatment became therefore exempted from the list of necessary procedures. However, the marketplace is returning to normality because of reduced lockout regulations and increasing medical doctor visits. In 2021, the marketplace recovered from the COVID-19 pandemic, leading to increasing demand for wound care products and revenue boom amongst producers.

Market players like B. Braun Melsungen AG and ConvaTec Group PLC are likely to growth their investment in R&D and introduce sophisticated merchandise, using call for for these goods, particularly in developed international locations. In October 2021, Healthium Medtech Limited brought ""TRUSHIELD NXT"", a surgical wound dressing with infection prevention and a 3D hydrocellular substrate for powerful wound safety.

Healthcare experts are an increasing number of the usage of bioactive treatments, which include skin replacements and boom hormones, to treat superior wounds. Several corporations are targeted on allograft, xenograft, nanofiber, dermal replacements, and cell-based treatments to fulfill the growing need for higher wound control amongst sufferers.

Comprehensive Analysis of Wound Care Market

The market is segmented into advanced dressings, traditional wound care products, negative pressure wound therapy, and bioactives. Advanced dressings dominate because of extended demand and advantages. Chronic wounds are ruled through the developing wide variety of diabetic foot ulcers and strain ulcers. The market is split into hospitals, clinics, and homecare settings. Hospitals are developing because of multispecialty departments, whilst homecare settings are predicted to see higher CAGR due to persistent wound occurrence and affected person shift in the direction of homecare remedies. Clinics also are expected to grow because of elevated funding and lengthy-time period care centers.

The North America region lead the wound care market share by benefitting a market size of USD 7.49 billion in 2023 because the area's marketplace dominance is attributed to essential gamers, a massive affected person populace with chronic and acute wounds, and extra healthcare expenditure per capita. According to 3M statistics, the remedy of diabetic foot ulcers in Canada charges over USD 547 million in line with year.

The worldwide wound care industry is semi-consolidated, with a few established firms dominating advanced wound dressings. In 2023, 3M, Smith & Nephew, ConvaTec Group PLC, and Mölnlycke Health Care AB held the worldwide market leadership position. Leading players retain their market dominance by introducing breakthrough wound treatment solutions, launching new products, and expanding sales channels.

In September 2023, MiMedx Group, Inc. announced EPIEFFECT, an enhanced wound care solution, to broaden its product line.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.5% from 2024-2032

Unit Value (USD billion)

Segmentation

By Type

- Advanced Wound Dressings

Antimicrobial Dressings

Alginate Dressings

Foam Dressings

Hydrocolloid Dressings

Others

- Traditional Wound Care Products

- Negative Pressure Wound Therapy

- Bioactives

Biological Skin Equivalents

Growth Factors

Others

- Others

By Application

- Chronic Wounds

Diabetic Foot Ulcers

Pressure Ulcers

Venous Leg Ulcers Others

- Acute Wounds

Surgical Wounds

Burns

By End User

- Hospitals

- Clinics

- Homecare Settings

- Others

By Region

- North America (By Type, By Application, By End User, By Country)

U.S. (By Application)

Canada (By Application)

- Europe (By Type, By Application, By End User, By Country/Sub-Region)

Germany (By Application)

U.K. (By Application)

France (By Application)

Italy (By Application)

Spain (By Application)

Scandinavia (By Application)

Rest of Europe (By Application)

- Asia Pacific (By Type, By Application, By End User, By Country/Sub-Region)

China (By Application)

Japan (By Application)

India (By Application)

Australia (By Application)

Southeast Asia (By Application)

Rest of Asia Pacific (By Application)

- Latin America (By Type, By Application, By End User, By Country/Sub-Region)

Brazil (By Application)

Mexico (By Application)

Rest of Latin America (By Application)

- Middle East & Africa (By Type, By Application, By End User, By Country/Sub-Region)

GCC (By Application)

South Africa (By Application)

Rest of Middle East & Africa (By Application)


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Chronic Wounds, by Key Countries, 2022/2023
4.2. New Product Launches, By Key Players
4.3. Key Industry Development: Mergers, Acquisitions, and Partnerships
4.4. Impact of COVID-19 on the Market
5. Global Wound Care Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Advanced Wound Dressings
5.1.1.1. Antimicrobial Dressings
5.1.1.2. Alginate Dressings
5.1.1.3. Foam Dressings
5.1.1.4. Hydrocolloid Dressings
5.1.1.5. Others
5.1.2. Traditional Wound Care Products
5.1.3. Negative Pressure Wound Therapy
5.1.4. Bioactives
5.1.4.1. Biological Skin Equivalents
5.1.4.2. Growth Factors
5.1.4.3. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Chronic Wounds
5.2.1.1. Diabetic Ulcers
5.2.1.2. Pressure Ulcers
5.2.1.3. Leg Ulcers
5.2.1.4. Others
5.2.2. Acute Wounds
5.2.2.1. Surgical Wounds
5.2.2.2. Burns
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Home Care Settings
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Wound Care Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Advanced Wound Dressingss
6.1.1.1. Antimicrobial Dressings
6.1.1.2. Alginate Dressings
6.1.1.3. Foam Dressings
6.1.1.4. Hydrocolloid Dressings
6.1.1.5. Others
6.1.2. Traditional Wound Care Products
6.1.3. Negative Pressure Wound Therapy
6.1.4. Bioactives
6.1.4.1. Biological Skin Equivalents
6.1.4.2. Growth Factors
6.1.4.3. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Chronic Wounds
6.2.1.1. Diabetic Ulcers
6.2.1.2. Pressure Ulcers
6.2.1.3. Leg Ulcers
6.2.1.4. Others
6.2.2. Acute Wounds
6.2.2.1. Surgical Wounds
6.2.2.2. Burns
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care Settings
6.3.4. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.1.1. By Application
6.4.2. Canada
6.4.2.1. By Application
7. Europe Wound Care Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Advanced Wound Dressingss
7.1.1.1. Antimicrobial Dressings
7.1.1.2. Alginate Dressings
7.1.1.3. Foam Dressings
7.1.1.4. Hydrocolloid Dressings
7.1.1.5. Others
7.1.2. Traditional Wound Care Products
7.1.3. Negative Pressure Wound Therapy
7.1.4. Bioactives
7.1.4.1. Biological Skin Equivalents
7.1.4.2. Growth Factors
7.1.4.3. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Chronic Wounds
7.2.1.1. Diabetic Ulcers
7.2.1.2. Pressure Ulcers
7.2.1.3. Leg Ulcers
7.2.1.4. Others
7.2.2. Acute Wounds
7.2.2.1. Surgical Wounds
7.2.2.2. Burns
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Home Care Settings
7.3.4. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. Germany
7.4.1.1. By Application
7.4.2. U.K.
7.4.2.1. By Application
7.4.3. France
7.4.3.1. By Application
7.4.4. Spain
7.4.4.1. By Application
7.4.5. Italy
7.4.5.1. By Application
7.4.6. Scandinavia
7.4.6.1. By Application
7.4.7. Rest of Europe
7.4.7.1. By Application
8. Asia Pacific Wound Care Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Advanced Wound Dressingss
8.1.1.1. Antimicrobial Dressings
8.1.1.2. Alginate Dressings
8.1.1.3. Foam Dressings
8.1.1.4. Hydrocolloid Dressings
8.1.1.5. Others
8.1.2. Traditional Wound Care Products
8.1.3. Negative Pressure Wound Therapy
8.1.4. Bioactives
8.1.4.1. Biological Skin Equivalents
8.1.4.2. Growth Factors
8.1.4.3. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Chronic Wounds
8.2.1.1. Diabetic Ulcers
8.2.1.2. Pressure Ulcers
8.2.1.3. Leg Ulcers
8.2.1.4. Others
8.2.2. Acute Wounds
8.2.2.1. Surgical Wounds
8.2.2.2. Burns
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Home Care Settings
8.3.4. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. Japan
8.4.1.1. By Application
8.4.2. China
8.4.2.1. By Application
8.4.3. India
8.4.3.1. By Application
8.4.4. Australia
8.4.4.1. By Application
8.4.5. Southeast Asia
8.4.5.1. By Application
8.4.6. Rest of Asia Pacific
8.4.6.1. By Application
9. Latin America Wound Care Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Advanced Wound Dressingss
9.1.1.1. Antimicrobial Dressings
9.1.1.2. Alginate Dressings
9.1.1.3. Foam Dressings
9.1.1.4. Hydrocolloid Dressings
9.1.1.5. Others
9.1.2. Traditional Wound Care Products
9.1.3. Negative Pressure Wound Therapy
9.1.4. Bioactives
9.1.4.1. Biological Skin Equivalents
9.1.4.2. Growth Factors
9.1.4.3. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Chronic Wounds
9.2.1.1. Diabetic Ulcers
9.2.1.2. Pressure Ulcers
9.2.1.3. Leg Ulcers
9.2.1.4. Others
9.2.2. Acute Wounds
9.2.2.1. Surgical Wounds
9.2.2.2. Burns
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Home Care Settings
9.3.4. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.4.1. Brazil
9.4.1.1. By Application
9.4.2. Mexico
9.4.2.1. By Application
9.4.3. Rest of Latin America
9.4.3.1. By Application
10. Middle East & Africa Wound Care Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Advanced Wound Dressingss
10.1.1.1. Antimicrobial Dressings
10.1.1.2. Alginate Dressings
10.1.1.3. Foam Dressings
10.1.1.4. Hydrocolloid Dressings
10.1.1.5. Others
10.1.2. Traditional Wound Care Products
10.1.3. Negative Pressure Wound Therapy
10.1.4. Bioactives
10.1.4.1. Biological Skin Equivalents
10.1.4.2. Growth Factors
10.1.4.3. Others
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Chronic Wounds
10.2.1.1. Diabetic Ulcers
10.2.1.2. Pressure Ulcers
10.2.1.3. Leg Ulcers
10.2.1.4. Others
10.2.2. Acute Wounds
10.2.2.1. Surgical Wounds
10.2.2.2. Burns
10.3. Market Analysis, Insights and Forecast – By End User
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Home Care Settings
10.3.4. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. GCC
10.4.1.1. By Application
10.4.2. South Africa
10.4.2.1. By Application
10.4.3. Rest of Middle East & Africa
10.4.3.1. By Application
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Smith & Nephew
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. financials (Based on Availability)
11.2.2. 3M
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. financials (Based on Availability)
11.2.3. ConvaTec Inc.
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. financials (Based on Availability)
11.2.4. Cardinal Health
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. financials (Based on Availability)
11.2.5. Coloplast A/S
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. financials (Based on Availability)
11.2.6. Mölnlycke Health Care AB
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. financials (Based on Availability)
11.2.7. Medtronic
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. financials (Based on Availability)
11.2.8. PAUL HARTMANN AG
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. financials (Based on Availability)
11.2.9. Johnson & Johnson Services, Inc.
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. financials (Based on Availability)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings